RK
Rajesh Kumar HSBC Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Eli Lilly
LLY
$652B
| $727.21 | $700 |
4%
downside
| Hold |
27 Aug ‘25
12 days ago |
|
2
IQVIA
IQV
$31.9B
| $187.68 | $160 |
15%
downside
| Hold |
25 Apr ‘25
4 months ago |
|
3
Keurig Dr Pepper
KDP
$38.9B
| $28.65 | $42 |
47%
upside
| Buy |
25 Apr ‘25
4 months ago |
|
4
AbbVie
ABBV
$375B
| $212.56 | $185 |
13%
downside
| Buy |
5 Jun ‘24
1 year ago |
|
5
Thermo Fisher Scientific
TMO
$186B
| $492.60 | $670 |
36%
upside
| Buy |
30 Apr ‘24
1 year ago |
|
6
Danaher
DHR
$143B
| $200.21 | $280 |
40%
upside
| Buy |
17 Apr ‘24
1 year ago |
|
7
UnitedHealth
UNH
$286B
| $315.39 | $460 |
46%
upside
| Hold |
4 Apr ‘24
1 year ago |
|
8
Teva Pharmaceuticals
TEVA
$21.7B
| $18.95 | $13 |
31%
downside
| Buy |
18 Dec ‘23
1 year ago |
|
9
Bristol-Myers Squibb
BMY
$96B
| $47.14 | $53 |
12%
upside
| Hold |
27 Oct ‘23
1 year ago |
|
10
Moderna
MRNA
$9.78B
| $25.14 | $97 |
286%
upside
| Reduce |
14 Jul ‘23
2 years ago |
|
11
BioNTech
BNTX
$27B
| $112.46 | $124 |
10%
upside
| Buy |
14 Jul ‘23
2 years ago |
|
12
Pfizer
PFE
$141B
| $24.88 | $50 |
101%
upside
| Buy |
14 Jul ‘23
2 years ago |
|
13
Merck
MRK
$212B
| $84.71 | $123 |
45%
upside
| Hold |
14 Jul ‘23
2 years ago |
|